| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |